KLRK1 and liver cancer: With regards to the role of NKG2D in liver cancer, there is no direct evidence that NKG2D+ CD8+ T cells promote HCC, but robust data support a detrimental effect of NKG2D+ CD8+ T cells during viral hepatitis.